Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Glycopyrronium bromide manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : China

Clear all

4 products found

glycopyrronium bromide

Solution for injection 0.2 mg, 0.4 mg - 1 ml , 2 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Manufacturer #12677
The company is a prominent pharmaceutical group established in 1971, dedicated to providing high-quality and effective healthcare products and services. With over 20 subsidiaries and more than 16,000 employees across major cities, the company emphasizes innovation and quality, operating four national R&D platforms. Recognized for its excellence, it has won multiple State Science and Technology Advancement Awards and holds international standards for Chinese medicinal materials included in the European Pharmacopoeia. The company focuses on quality-first and efficiency-priority principles, aiming to enhance health outcomes while continuously advancing in the global healthcare industry.

Manufacturer usually replies in 4 days

glycopyrronium bromide + formoterol

Pressurised inhalation 9 mcg + 4.8 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
TGA, INVIMA, ANVISA, China
Manufacturer #36629

Established in 1993, this manufacturer employs over 1,100 staff and operates advanced production lines for metered dose inhalers, nasal sprays, dry powder inhalers, and nebulizer solutions. As a CTD dossier owner and manufacturer, it holds GMP approvals from more than 20 countries, including Australia. The manufacturer is recognized as a CTD dossier owner and manufacturer, and its products are distributed in over 90 countries worldwide. With a focus on innovation, the manufacturer is a CTD dossier owner and manufacturer, dedicated to developing high-end generic drugs

Manufacturer usually replies in nan days

glycopyrronium bromide

Inhalation powder 50 mcg

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
China
Manufacturer #20131

This fully integrated specialty pharmaceutical company focuses on researching, manufacturing, and marketing respiratory drug products globally. Their therapeutic areas include allergic rhinitis, asthma, COPD, respiratory infections, pulmonary fibrosis, and pulmonary hypertension. They offer various dosage forms, including inhalation sprays (SMI), metered-dose inhalers (MDI), dry powder inhalers (DPI), nebulizations, nasal sprays, and liposomes. The company boasts over 30 patents and a team of more than 100 R&D personnel. They have received recognition as a top employer in their region and secured significant funding to support the development of high-end inhalation products. Their operations extend across key regions like the EU and North America.

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Glycopyrronium Bromide Manufacturers

Markets of interest

As an antispasmodic Glycopyrronium Bromide prescribed to treat some disorders of the gastrointestinal tract and to reduce salivation with some anesthetics. The substance is available for sale in the form of ampoules, solution for injection, capsules, from manufacturers in various countries including Y. The drug is provided by a wide range of Glycopyrronium Bromide suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Glycopyrronium Bromide manufacturers and distributors are based in China Bangladesh, and Turkey.

Licensing and brand names

In October 2015, Glycopyrronium Bromide was approved by the FDA for use as a standalone treatment for Chronic obstructive pulmonary disease (COPD) in the USA. The medication was approved by the EMA in the European Union in 2012. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Cuvposa, Enurev Breezhaler. One of the most popular branded versions of Glycopyrronium Bromide is manufactured and supplied by the Dutch pharmaceutical company Duchefa Farma B.V. Other manufacturing companies and distributors from India, Spain, Switzerland, Portugal, France, and Italy have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Glycopyrronium Bromide as an active ingredient.

Target supply price

The wholesale acquisition cost for Glycopyrronium Bromide injectable solution (0.2 mg/mL) is around $67 for a supply of 25 milliliters. The retail price of 85mcg + 43 mcg inhalable powder (hard capsules) N30 x 1 + 1 inhaler 46.45 € of the substance in Europe reaches EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Glycopyrronium Bromide manufacturers and suppliers that you are looking for. You can also find the dossier status of Glycopyrronium Bromide and the GMP approvals of the different variants of the medication. The product description of all Glycopyrronium Bromide suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Glycopyrronium Bromide is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible